Cargando…
Genetic Influences on Response to Mood Stabilizers in Bipolar Disorder: Current Status of Knowledge
Mood stabilizers form a cornerstone in the long-term treatment of bipolar disorder. The first representative of their family was lithium, still considered a prototype drug for the prevention of manic and depressive recurrences in bipolar disorder. Along with carbamazepine and valproates, lithium bel...
Autor principal: | Rybakowski, Janusz K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing AG
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602611/ https://www.ncbi.nlm.nih.gov/pubmed/23378337 http://dx.doi.org/10.1007/s40263-013-0040-7 |
Ejemplares similares
-
Bipolar mood disorder and treatment-resistant depression
por: Rybakowski, Janusz K
Publicado: (2010) -
Mood Stabilizers of First and Second Generation
por: Rybakowski, Janusz K.
Publicado: (2023) -
Role of Viral Infection in the Aetiology of Multiple Sclerosis: Status of Current Knowledge and Therapeutic Implications
por: Berti, Rossana, et al.
Publicado: (2012) -
The Purinergic System as a Target for the Development of Treatments for Bipolar Disorder
por: Gonçalves, Maria Carolina Bittencourt, et al.
Publicado: (2022) -
Application of Antipsychotic Drugs in Mood Disorders
por: Rybakowski, Janusz K.
Publicado: (2023)